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 Abstract (if necessary) 
We reported a probable case of allergic contact dermatitis three weeks after the H1N1 
vaccine, involving thimerosal additive. Patients should be aware of this possible problem with 
this unusual delayed reaction.   
 Thimerosal is a traditional high-prevalence allergen in the general population, which has been 
used as an antimicrobial agent in contact lens and vaccines (1). However, prevalence in the 
general population is decreasing in many countries, such as reactions to thimerosal, because 
of the exclusion of thimerosal in vaccines (2). We reported a probable case of allergic contact 
dermatitis three weeks after the H1N1 vaccine, involving thimerosal additive.  
 
A 55 year-old woman, who is a medical doctor, noticed an important skin reaction on her left 
arm (figure 1). The lesion was characterized by erythema and edema, followed by the 
appearance of papules and vesicles. The skin reaction was exactly at the same site of injection 
of the Influenza A H1N1 vaccine (Pandemrix© vaccine, Influenza A H1N1 2009 Monovalent 
AS03-Adjuvanted Vaccine, GSK), but 22 days after the shot. No history of atopy or 
documented allergic contact dermatitis was found. Only moderate pruritus occurred, with only 
one application of topical steroid. She had no other significant medical condition of any kind 
and no treatment at this time. The patch test of thimerosal (thiomersal, additive of the 
vaccine) was weakly positive a week after the initial visit (‘+’, erythema, infiltration and 
papules). The evolution was favorable with disappearance in three weeks. A complete testing, 
including most of the component of the vaccine was performed two month later, in order to 
avoid recurrence and to confirm the association with thiomerosal. The patch test only found a 
positivity for thimerosal (but important this time ‘+++’), and was involved in the allergic 
contact dermatitis presented by our colleague.  
 
There is a debate about thimerosal reactions: some studies raised the possibility that most of 
the positive reactions to it are irrelevant. However, even though reactions are to it are 
decreasing, there a consistency about thimerosal sensitivity does exist in contact dermatitis 
patients (3). Immediate generalized reaction to thimerosal from an influenza vaccine have 
been previously reported (4-6), but this was the first reported case of allergic contact 
dermatitis three weeks after the H1N1 vaccine, probably caused by thimerosal additive.  
 
Allergic contact dermatitis presented by our colleague come from delayed-type 
hypersensitivity reaction (7), mediated by hapten-specific T cells (8). Even though T-cell 
mediated reactions usually starting from 2–8 hours up to 2 days after vaccination (9), very late 
reactions have been described for other medications [up one month (10)]. Other differential 
cause of acute dermatitis has been excluded by anamnesis and patch tests. No cause of 
immunodeficiency has been found. It is however possible, the lesion appeared before our 
colleague noticed it, but only a few days before. 
In conclusion, we report an allergic contact dermatitis involving thimerosal additive. Patient 
should be aware of this possible problem with this unusual delayed reaction. 
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Figure 1 Eczema lesion of left shoulder, three days after the beginning of the rash (25 days 
after the H1N1 vaccine shot). 
 
